Acetic Acid → 5-(N-tert-butoxycarbonyl-L-methionyloxy)-7-chloro-1-[2-methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine

HRID 54746

반응식

HRID 54746 반응식
[OH:1][CH:2]1[C:8]2[CH:9]=[C:10]([Cl:13])[CH:11]=[CH:12][C:7]=2[N:6]([C:14](=[O:33])[C:15]2[CH:20]=[CH:19][C:18]([NH:21][C:22](=[O:30])[C:23]3[CH:28]=[CH:27][CH:26]=[CH:25][C:24]=3[CH3:29])=[CH:17][C:16]=2[O:31][CH3:32])[CH2:5][CH2:4][CH2:3]1.CN([C:37]1[CH:42]=[CH:41]C=CN=1)C.Cl.CN(C1C=CC=CN=1)C.C(O[NH:58][C@H:59]([C:66]([OH:68])=O)[C:60](=C=O)[CH2:61][S:62][CH3:63])(C)(C)C.[CH:69]1(N=C=NC2CCCCC2)CCCCC1.[C:84]([OH:87])(=[O:86])C>C(Cl)(Cl)Cl.CO>[C:42]([O:87][C:84]([NH:58][C@H:59]([C:66]([O:1][CH:2]1[C:8]2[CH:9]=[C:10]([Cl:13])[CH:11]=[CH:12][C:7]=2[N:6]([C:14](=[O:33])[C:15]2[CH:20]=[CH:19][C:18]([NH:21][C:22](=[O:30])[C:23]3[CH:28]=[CH:27][CH:26]=[CH:25][C:24]=3[CH3:29])=[CH:17][C:16]=2[O:31][CH3:32])[CH2:5][CH2:4][CH2:3]1)=[O:68])[CH2:60][CH2:61][S:62][CH3:63])=[O:86])([CH3:41])([CH3:37])[CH3:69]

참가 물질

9

반응물 6

HCID 176Acetic AcidHCID 10868DicyclohexylcarbodiimideHCID 218852-DimethylaminopyridineHCID 189174175-Hydroxy-7-chloro-1-[2-methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepineHCID 22461520Dimethylaminopyridine hydrochlorideHCID 86750746N-tert-butoxy-carbonyl-L-methionine

생성물 1

HCID 228720795-(N-tert-butoxycarbonyl-L-methionyloxy)-7-chloro-1-[2-methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine

시약·촉매·용매 2

HCID 887Methanol용매HCID 6212Chloroform용매

실험 절차

In 15 ml of chloroform were dissolved 0.7 g of 5-hydroxy-7-chloro-1-[2-methoxy-4-(2methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzoazepine, 0.83 g of dimethylaminopyridine and 0.72 g of dimethylaminopyridine hydrochloride. Thereto were added 0.56 g of N-tert-butoxy-carbonyl-L-methionine and 0.93 g of dicyclohexylcarbodi-imide. The mixture was stirred at room temperature for 3 hours. 3 ml of methanol and 0.7 ml of acetic acid were added, and the mixture was stirred at room temperature for 30 minutes. The resulting insolubles were removed by filtration. The filtrate was mixed with a 5% aqueous sodium hydrogensulfate solution, followed by extraction with dichloromethane. The dichloromethane layer was washed with a saturated aqueous sodium hydrogencarbonate solution and a saturated aqueous sodium chloride solution in this order and dried over magnesium sulfate. The resulting dichloromethane solution was concentrated for solvent removal. The residue was purified by silica gel column chromatography [elutant: dichloromethane/methanol=150/1] to obtain 1.27 g of 5-(N-tert-butoxycarbonyl-L-methionyloxy)-7-chloro-1-[2-methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzo-azepine.

후처리

  1. stirringthe mixture was stirred at room temperature for 30 minutes
  2. customThe resulting insolubles were removed by filtration
  3. additionThe filtrate was mixed with a 5% aqueous sodium hydrogensulfate solution
  4. extractionfollowed by extraction with dichloromethane
  5. washThe dichloromethane layer was washed with a saturated aqueous sodium hydrogencarbonate solution
  6. dry with materiala saturated aqueous sodium chloride solution in this order and dried over magnesium sulfate
  7. concentrationThe resulting dichloromethane solution was concentrated for solvent removal
  8. customThe residue was purified by silica gel column chromatography [elutant: dichloromethane/methanol=150/1]

출처 및 근거

ORD 기록
ord-6540c8ed439b4d91a3b40376c4ba882f
출처 데이터셋
uspto-grants-1997_04
특허 번호
US05622947

연결된 노트

불러오는 중…